Mediastinal growing teratoma syndrome Journal Article


Authors: Afifi, H. Y.; Bosl, G. J.; Burt, M. E.
Article Title: Mediastinal growing teratoma syndrome
Abstract: Background. The growing teratoma syndrome refers to the phenomenon whereby germ cell tumors enlarge after chemotherapy despite complete eradication of malignant cells and normalization of serum tumor markers. This clinical scenario must be differentiated from that in which germ cell tumors maintain their malignant characteristics with elevated levels of serum tumor markers. Methods. Hospital record review was conducted of 2 cases. Results. Two male patients are presented, 1 with a metastatic germ cell tumor of both the retroperitoneum and mediastinum (with elevated α- fetoprotein level) and 1 with a primary germ cell tumor of the mediastinum (with elevated α-fetoprotein and β-human chorionic gonadotropin levels). After completion of chemotherapy and normalization of tumor markers, both patients presented with pulmonary symptoms attributable to their massively enlarging mediastinal teratomas. The clinical and roentgenographic features of patients with thoracic manifestations of the growing teratoma syndrome, as well as its management, are reviewed. Conclusions. After chemotherapy in patients with primary or metastatic mediastinal germ cell tumors whose tumor markers normalize, a growing mass in the mediastinum may represent the growing teratoma syndrome.
Keywords: adult; human tissue; case report; lymph node dissection; computer assisted tomography; thoracotomy; tumor marker; syndrome; testicular neoplasms; teratoma; thorax radiography; orchiectomy; germ cell tumor; sternotomy; mediastinal neoplasms; retroperitoneal cancer; chorionic gonadotropin beta subunit; chorionic gonadotropin, beta subunit, human; alpha fetoprotein; mediastinum metastasis; mediastinum mass; alpha-fetoproteins; malignant teratoma; humans; human; male; priority journal; article
Journal Title: Annals of Thoracic Surgery
Volume: 64
Issue: 2
ISSN: 0003-4975
Publisher: Elsevier Science, Inc.  
Date Published: 1997-08-01
Start Page: 359
End Page: 362
Language: English
DOI: 10.1016/s0003-4975(97)00581-x
PUBMED: 9262575
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 17 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. George Bosl
    430 Bosl
  2. Michael E. Burt
    187 Burt